Prosser Memorial Hospital Critical Access Hospital (Medicare Certified) Location: 723 Memorial Street, Prosser, Washington 99350 Ratings: Phone: (509) 786-2222 |
News Archive
Neuralstem, Inc. announced that the first subject was dosed yesterday in a Phase Ia trial to evaluate the safety of its drug, NSI-189, which is being developed for the treatment of major depressive disorder and other psychiatric indications. NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform. This phase of the trial is in healthy volunteers and seeks to determine the maximum tolerated single dose.
Health officials from 16 countries today asked for budgetary support "to ensure the sustainability of the existing vaccination programs and the introduction of new vaccines," at the conclusion of a global symposium on rotavirus, a diarrheal disease that kills over 600,000 children worldwide every year.
The European drugs regulator, the European Medicines Agency (EMEA) is calling for warnings to be placed on the the anti smoking drug Champix (varenicline).
African-American women battling vitamin D deficiencies need the same dose as Caucasian women to treat the condition, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
Greenway Medical Technologies, Inc., announced today that Greenway PrimeSUITE 2014 (17.0) is compliant with the ONC 2014 Edition criteria and was certified as an EHR Module on Jan. 15, 2013 by the Certification Commission for Health Information Technology (CCHIT), an ONC-ACB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.
› Verified 1 days ago